Basal Cell Carcinoma
📧 Sign up to get email alerts when something new happens for Basal Cell Carcinoma.
Sign up freeTop drugs studied for this disease
-
FDA label_change · 2023-03-27FDA Approved: ERIVEDGE — Supplemental Application (Genentech, Inc.)
FDA approved a supplemental application for ERIVEDGE (vismodegib) from Genentech, Inc., resulting in labeling changes.